DuPont de Nemours Inc
For the period ended Mar 31, 2024. Filed May 1, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 1, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Supplementary Information
NOTE 7 -SUPPLEMENTARY INFORMATION
| Sundry Income (Expense) - Net | Three Months Ended March 31, | |
|---|---|---|
| In millions | 2024 | 2023 |
| Non-operating pension and other post-employment benefit credits (costs) | $7 | $(2) |
| Interest income 1 | 20 | 46 |
| Net gain on divestiture and sales of other assets and investments | 2 | 6 |
| Foreign exchange gains (losses), net | 4 | (20) |
| Miscellaneous income (expense) - net | 5 | (1) |
| Sundry income (expense) - net | $38 | $29 |
- The three months ended March 31, 2024 includes non-cash interest income of$6 million related to the$350 million Delrin® related party note receivable. Refer to Note 11 for additional information.
Cash, Cash Equivalents and Restricted Cash
At March 31, 2024 and December 31, 2023 the Company had $413 million and $411 million, respectively, within “Restricted cash and cash equivalents”. The majority of these balances are attributable to the Water District Settlement Fund. Additional information can be found in Note 14.
Accrued and Other Current Liabilities
"Accrued and other current liabilities" in the interim Condensed Consolidated Balance Sheets were $1,255 million at March 31, 2024 and $1,269 million at December 31, 2023. "Accrued and other current liabilities" at March 31, 2024 and December 31, 2023 includes approximately $408 million and $405 million, respectively, related to a settlement agreement further discussed in Note 14. Accrued payroll, which is a component of "Accrued and other current liabilities," was $197 million at March 31, 2024 and $250 million at December 31, 2023. No other component of "Accrued and other current liabilities" was more than 5 percent of total current liabilities at March 31, 2024 and at December 31, 2023.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.